
Abeona Therapeutics (ABEO) P/E Ratio
P/E Ratio as of Jul 1, 2025: -4.17
Average-4.57
Median-4.49
Minimum-5.04
Maximum-4.17
-4.17
Past Month+0.50 (10.71%)
The P/E ratio for Abeona Therapeutics (ABEO) is -4.17 as of Jul 1, 2025. This represents a increase of 59.16% compared to its 12-month average P/E ratio of -2.62. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Abeona Therapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Abeona Therapeutics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Abeona Therapeutics to industry peers.
Abeona Therapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Abeona Therapeutics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Abeona Therapeutics to industry peers.
Abeona Therapeutics (ABEO) P/E Ratio Insights
See Abeona Therapeutics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Abeona Therapeutics (ABEO)
Order type
Buy in
Order amount
Est. shares
0 shares
Abeona Therapeutics (ABEO) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jul 1, 2025 | $5.57 | -4.17 |
Jun 2, 2025 | $6.28 | -4.70 |
May 1, 2025 | $6.87 | -3.05 |
Apr 1, 2025 | $4.45 | -1.98 |
Mar 3, 2025 | $5.09 | -1.89 |
Feb 3, 2025 | $5.50 | -2.04 |
Jan 2, 2025 | $5.91 | -2.19 |
Abeona Therapeutics (ABEO) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -4.17 | +101.45% |
2024 | -2.07 | -17.20% |
2023 | -2.50 | +1,370.59% |
2022 | -0.17 | -57.50% |
2021 | -0.40 | -76.88% |
2020 | -1.73 | — |
FAQs About Abeona Therapeutics (ABEO) P/E ratio
The latest P/E ratio of Abeona Therapeutics (ABEO) is -4.17, as of Jul 1, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Abeona Therapeutics’s last 12-month average P/E ratio is -2.62, compared to its current P/E ratio of -4.17. This reflects a increase of 59.16%.
Abeona Therapeutics’s current P/E ratio of -4.17 is higher than its last 12-month average P/E of -2.62. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Abeona Therapeutics’s average P/E ratio over the last 3 years is -1.67. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Abeona Therapeutics’s average P/E ratio over the last 5 years is -1.63. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.